Tubeimoside-2 Triggers Methuosis in Hepatocarcinoma Cells through the MKK4–p38α Axis
Liver cancer, consisting mainly of hepatocellular carcinoma, is the third leading cause of cancer-related mortality worldwide. Despite advances in targeted therapies, these approaches remain insufficient in meeting the pressing clinical demands. Here, we present a novel alternative that calls for a...
Main Authors: | Yichao Gan, Chen Wang, Yunyun Chen, Linxin Hua, Hui Fang, Shu Li, Shoujie Chai, Yang Xu, Jiawei Zhang, Ying Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/4/1093 |
Similar Items
-
Tubeimoside 1 Acts as a Chemotherapeutic Synergist via Stimulating Macropinocytosis
by: Xianling Gong, et al.
Published: (2018-09-01) -
Corrigendum: Tubeimoside 1 Acts as a Chemotherapeutic Synergist via Stimulating Macropinocytosis
by: Xianling Gong, et al.
Published: (2021-07-01) -
Tubeimoside-1 Inhibits Glioblastoma Growth, Migration, and Invasion via Inducing Ubiquitylation of MET
by: Jiangjun Cao, et al.
Published: (2019-07-01) -
Methuosis Contributes to Jaspine-B-Induced Cell Death
by: Núria Bielsa, et al.
Published: (2022-06-01) -
Adjuvant activity of tubeimosides by mediating the local immune microenvironment
by: Ziyi Han, et al.
Published: (2023-02-01)